Vivek Pravin Dave Rajeev R Pappuru
10.4103/0301-4738.178143
Indian J Ophthalmol
2016 Jan;64(1):87-8.
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/26953030/
Angiogenesis Inhibitors / therapeutic use Bevacizumab / therapeutic use Macular Edema / diagnosis Optic Neuropathy, Ischemic / diagnosis Subretinal Fluid
Angiogenesis Inhibitors / therapeutic use Bevacizumab / therapeutic use Macular Edema / diagnosis Optic Neuropathy, Ischemic / diagnosis Subretinal Fluid Case Reports Acute Disease Arteritis / diagnosis Arteritis / drug therapy Humans Intravitreal Injections Macular Edema / drug therapy Male Middle Aged Optic Neuropathy, Ischemic / drug therapy Tomography, Optical Coherence Vascular Endothelial Growth Factor A / antagonists & inhibitors Visual Field Tests Angiogenesis Inhibitors VEGFA protein, human Vascular Endothelial Growth Factor A Bevacizumab
PMC4821128
26953030
An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
2016